Joint Formulary & PAD

Octreotide acetate - Sulphonylurea overdose

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Red
Formulations :

No records returned.

Associated Icons :
SPC
Restrictions / Comments :

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Octreotide acetate
Indication :
Sulphonylurea overdose
Group Name :
Keywords :
sulphonylurea toxicity, sulphonylurea induced hypoglycaemia
Brand Names Include :
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0

Committee Recommendations (1)

The Surrey Heartlands Area Prescribing Committee agreed the traffic light status of this drug and indication as part of the Joint Formulary review.

Other Indications

Below are listed other indications that Octreotide acetate is used to treat.

Other Drugs

Below are listed other drugs that are used to treat Sulphonylurea overdose.

  • No records returned.